Viscerotropic and neurotropic velogenic strains of Newcastle disease virus (NDV) have been isolated during disease outbreaks in the United States since May 1971. These viruses have caused high mortality in vaccinated poultry flocks. In this study, two commercial lentogenic NDV vaccines were shown to afford protection to challenge exposure to velogenic strains suggesting a re-examination of vaccination procedures.
INTRODUCTION
Severe mortality attributed to Newcastle disease outbreaks in commercial poultry flocks vaccinated against Newcastle disease virus (NDV) has occurred in several areas of the United States since May 1971. A neurotropic velogenic strain was isolated from the Southwest (Texas and New Mexico) and a viscerotropic velogenic Newcastle disease virus (VVND) was isolated during an outbreak in the South (Florida). Consequently, the efficacy of commercial vaccines against velogenic NDV challenge has been questioned. This laboratory study was undertaken to evaluate the efficacy of the B1 and LaSota vaccines (2,3) against challenge exposure to VVND (Largo-Florida) and a neurotropic velogenic NDV (Texas-219). All three viruses were passed via the chorio-allantoic sac of 10-day-old susceptible embryonating chicken eggs and titrated via the same route. Stock viruses were harvested as amnio-allantoic fluid of embryos dying 48 to 72 hours postinoculation and were stored at -70 C.
MATERIALS AND METHODS

Challenge
Chickens. Nine-week-old NDV-susceptible White Leghorn cockerels were used.
Vaccines. Commercial vaccines made from two lentogenic NDV strains (B1 and LaSota) were supplied by the late Dr. Dale Oshel, National Animal Disease Laboratory, Ames, Iowa. The vaccines were reconstituted and used according to the manufacturer's recommendations and contained log108s0 B1/ml and log107 6 LaSota/ml.
Procedures. The efficacy of the two commercial vaccines was tested by intranasal vaccination of susceptible poultry followed by intramuscular challenge. These intramuscular challenge inoculations were performed to fulfill criteria of the Veterinary Biologics Division, ARS, USDA. The intramuscular route was preferred as the challenge dose was more precise and bird response more predictable. Approximately 200 cockerels were divided into three groups and housed in separate isolation rooms. One of the rooms contained the unvaccinated controls, while chickens in the other two rooms were vaccinated intranasally with one drop of the B1 or LaSota vaccine per bird, one vaccine per room.
Three weeks postvaccination, chickens from each of the three rooms were divided randomly to represent one-third of the chickens from each original treatment group. Chickens were challengeinoculated intramuscularly with 150,000 chicken-embryo-lethal doses in 0.5 ml of the Texas-219, Largo-Florida, and GB strains, one virus per room. The birds were observed for clinical signs for 14 days postchallenge.
Blood samples were taken before vaccination and two weeks postchallenge and tested for antibody to NDV by the hemagglutination-inhibition test using four hemagglutination units of the GB strain of NDV. The lowest serum dilution tested was 1/80. 
RESULTS
Texas-219, Largo-Florida, and the GB strain killed the chicken embryos at 48 to 72 hours postinoculation and titered loglo8 5-90/0.2 ml. All three challenge viruses killed all unvaccinated control birds between 2 and 7 days postchallenge, whereas the groups vaccinated with B1 and LaSota were afforded 90.5 to 100% protection (Table   1 ).
All birds tested for antibody to NDV by the HI test were negative before vaccination. Postchallenge HI titers indicated that HI titers were higher when the chickens were challenge-exposed to the VVND (Largo-Florida) than when the neurotropic challenge viruses were used ( Table 2 ). In calculating the geometric mean HI titers, the HI = <80 was considered to be HI = 40.
DISCUSSION
While the NDV vaccines selected for study reportedly provided questionable protection in the field, these same vaccines administered intranasally gave excellent protection against velogenic NDV challenge-exposure under laboratory conditions. This study did not take place under field conditions nor does it provide data relative to duration of immunity against velogenic NDV strains. However, these lentogenic vaccines protected chickens against challenge-exposure to field isolates from recent outbreaks in Florida and Texas that caused high mortality in vaccinated poultry. The results warrant an appraisal of vaccination procedures as presently applied.
Prechallenge serum samples were not collected so that an anamnestic response could not be described. Sera from vaccinated chickens surviving field outbreaks of velogenic NDV have had low HI titers indicating poor response to field vaccination. The relatively high HI titers found in sera of chickens used in this study where the vaccine was individually applied and the immunity of the birds challenged by intramuscular virus challenge inoculation further suggest the need for better vaccination management, especially where these viscerotropic strains are involved.
